Amended Annual Report Reveals $24.36M Loss, Ineffective Internal Controls, and Significant Franchisee Decline
BYAH sits 16% above its 52-week low of $0.93.
Summary
Park Ha Biological Technology filed an amended annual report disclosing a $24.36 million net loss, ineffective internal controls, a significant drop in franchisees, and increased credit losses, alongside details of a recent capital raise and reverse stock split.
Key Events · Corporate Governance and Compliance · BYAH
-
Substantial Net Loss Reported
The company reported a net loss of $24,364,753 for the fiscal year ended October 31, 2025, a significant reversal from a net income of $478,561 in the prior year. This loss was primarily driven by a $24,070,200 non-cash share-based compensation expense.
-
Internal Control Over Financial Reporting Deemed Ineffective
Management concluded that the company's internal control over financial reporting was 'not effective' as of October 31, 2025, citing insufficient in-house personnel with adequate knowledge of U.S. GAAP and SEC reporting rules as a material weakness.
-
Significant Decline in Franchisees and Increased Credit Risk
The number of franchisees decreased from 45 in 2024 to 22 in 2025, contributing to a 10% drop in franchise fee revenue. The allowance for expected credit losses on franchisee loans increased significantly to $232,876, with $0.9 million in loans due from terminated franchisees.
-
Recent Capital Raise and Reverse Stock Split
The company completed a public offering on January 28, 2026, raising $2.45 million in gross proceeds by selling 21,875,000 units, each including a Class A Ordinary Share and a warrant. This was followed by a 1-for-50 reverse stock split effective February 20, 2026, to regain Nasdaq compliance.
Analysis · BYAH · Industrial Applications And Services
This amended annual report highlights severe financial and operational challenges for Park Ha Biological Technology. The company reported a substantial net loss, primarily driven by a large non-cash share-based compensation expense. Critically, management identified a material weakness in its internal controls over financial reporting, indicating significant deficiencies in financial oversight. The sharp decline in franchisees and a notable increase in uncollectible loans from them point to operational instability and heightened credit risk. While the company successfully raised capital and executed a reverse stock split, these actions appear reactive to underlying financial distress and Nasdaq compliance issues. Investors should be highly concerned about the company's financial health, internal control environment, and the sustainability of its franchise model.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 42.6% of the 488 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.42%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BYAH was trading at $1.08 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.5M. The 52-week trading range was $0.93 to $2,074.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.